Roche announced the CE-IVD launch of cobas® TV/MG, for use on the cobas 6800/8800 Systems for the direct detection of Trichomonas vaginalis (TV) and/or Mycoplasma genitalium (MG) DNA in both symptomatic and asymptomatic individuals. cobas TV/MG offers labs the broadest set of specimen claims available in one test, including the ability to test for both TV and MG from one patient sample. This new flexibility can aid health care professionals in faster diagnosis and in reducing the testing volume for labs, while enabling fewer sample collections from patients. cobas TV/MG has been validated for use with the same, full set of female urogenital specimens available for use with cobas CT/NG.1 In addition, the test has been validated for use with male urine and is the first CE-IVD molecular test to receive a claim for combo TV/MG testing using a meatal swab specimen. The fully automated cobas 6800/8800 Systems offer the faster time to results, the higher throughput and the longest walk-away time available among automated molecular platforms, providing laboratories with improved operating efficiency and the flexibility to adapt to changing testing demands.